Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06737393 · ClinicalTrials.gov registry record · NA
Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge
A NA study of Patient Discharge and Urinary Complication, sponsored by University of Tennessee.
- Recruiting
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT06737393: Recruiting NA study of Patient Discharge and Urinary Complication, sponsored by University of Tennessee.
NCT06737393 is a NA study of Patient Discharge and Urinary Complication that is actively recruiting participants, run by University of Tennessee. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06737393, a NA study of Patient Discharge and Urinary Complication, is actively recruiting participants, sponsored by University of Tennessee.
- RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that backfilling the bladder postoperatively will reduce time to spontaneous void and subsequent discharge from the post-anesthesia care unit.
Conditions Studied
Interventions
- PROCEDURE Backfill
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2026-01-01 |
| Phase | NA |
What NCT06737393 shows while recruiting
NCT06737393 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Patient Discharge appearing as the primary indexed condition, and to 1 intervention - of which Backfill is the first listed.
NCT06737393 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06737393 about?
NCT06737393 is a clinical study titled "Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge". The investigators hypothesize that backfilling the bladder postoperatively will reduce time to spontaneous void and subsequent discharge from the post-anesthesia care unit.
What is the current status of trial NCT06737393?
This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2025-01-01. Estimated completion is 2026-01-01.
What conditions does trial NCT06737393 study?
This clinical trial studies the following conditions: Patient Discharge, Urinary Complication.
What interventions are being tested in trial NCT06737393?
The interventions under investigation include: Backfill (PROCEDURE).
Who is sponsoring clinical trial NCT06737393?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06737393 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Discharge
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06737393's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI